Shanghai Pharmaceuticals Holding Co., Ltd

OTCPK:SHPM.Y Stock Report

Market Cap: US$8.2b

Shanghai Pharmaceuticals Holding Management

Management criteria checks 2/4

Shanghai Pharmaceuticals Holding's CEO is Bo Shen, appointed in Mar 2010, has a tenure of 14.08 years. total yearly compensation is CN¥5.80M, comprised of 21.5% salary and 78.5% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth $158.46K. The average tenure of the management team and the board of directors is 1.7 years and 0.8 years respectively.

Key information

Bo Shen

Chief executive officer

CN¥5.8m

Total compensation

CEO salary percentage21.5%
CEO tenure14.1yrs
CEO ownership0.002%
Management average tenure1.7yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bo Shen's remuneration changed compared to Shanghai Pharmaceuticals Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥6mCN¥1m

CN¥4b

Sep 30 2023n/an/a

CN¥5b

Jun 30 2023n/an/a

CN¥5b

Mar 31 2023n/an/a

CN¥6b

Dec 31 2022CN¥6mCN¥1m

CN¥6b

Sep 30 2022n/an/a

CN¥5b

Jun 30 2022n/an/a

CN¥5b

Mar 31 2022n/an/a

CN¥4b

Dec 31 2021CN¥6mCN¥1m

CN¥5b

Sep 30 2021n/an/a

CN¥5b

Jun 30 2021n/an/a

CN¥6b

Mar 31 2021n/an/a

CN¥6b

Dec 31 2020CN¥5mCN¥1m

CN¥4b

Sep 30 2020n/an/a

CN¥4b

Jun 30 2020n/an/a

CN¥4b

Mar 31 2020n/an/a

CN¥4b

Dec 31 2019CN¥6mCN¥1m

CN¥4b

Sep 30 2019n/an/a

CN¥4b

Jun 30 2019n/an/a

CN¥4b

Mar 31 2019n/an/a

CN¥4b

Dec 31 2018CN¥3mCN¥800k

CN¥4b

Sep 30 2018n/an/a

CN¥4b

Jun 30 2018n/an/a

CN¥4b

Mar 31 2018n/an/a

CN¥4b

Dec 31 2017CN¥2mCN¥800k

CN¥4b

Compensation vs Market: Bo's total compensation ($USD801.18K) is below average for companies of similar size in the US market ($USD8.28M).

Compensation vs Earnings: Bo's compensation has been consistent with company performance over the past year.


CEO

Bo Shen (50 yo)

14.1yrs

Tenure

CN¥5,800,000

Compensation

Mr. Bo Shen has been the Chief Financial Officer of Shanghai Pharmaceuticals Holding Co., Ltd. since March 2010 and serves as its Head of the Accounting Department. He serves as President of Shanghai Pharm...


Leadership Team

NamePositionTenureCompensationOwnership
Qiuhua Yang
Executive Chairmanless than a yearno datano data
Bo Shen
President14.1yrsCN¥5.80m0.0019%
CN¥ 158.5k
Yongzhong Li
VP & Executive Directorno dataCN¥6.19mno data
Ming Dong
Executive Directorless than a yearno datano data
Tao Zhong
VP, Board Secretary & Joint Company Secretary1.7yrsCN¥3.12mno data
Dongming Li
Vice President2.1yrsCN¥3.12mno data
Shuai Shao
Vice President1.7yrsCN¥2.08mno data
Shunjiang Yu
Chief Medical Officerno datano datano data
Pui Kiu Wong
Joint Company Secretaryless than a yearno datano data
Ying Ke
Director & General Manager of R&D Management Centerno datano datano data
Linqiong Dong
Securities Affairs Representativeno datano datano data

1.7yrs

Average Tenure

51yo

Average Age

Experienced Management: SHPM.Y's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Qiuhua Yang
Executive Chairmanless than a yearno datano data
Bo Shen
President10.8yrsCN¥5.80m0.0019%
CN¥ 158.5k
Yongzhong Li
VP & Executive Director10.8yrsCN¥6.19mno data
Ming Dong
Executive Directorless than a yearno datano data
Manson Fok
Independent Non-Executive Director4.8yrsCN¥300.00kno data
Youli Xu
Chief Supervisor7.8yrsno datano data
Zhaoyang Gu
Independent Non-Executive Director4.8yrsCN¥300.00kno data
Weidong Yu
Employee Representative Supervisorless than a yearno datano data
Fashu Chen
Non-Executive Directorless than a yearno datano data
Jia Ma
Supervisorless than a yearno datano data
Zhong Wang
Independent Non-Executive Directorless than a yearCN¥150.00kno data

0.8yrs

Average Tenure

52yo

Average Age

Experienced Board: SHPM.Y's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.